Literature DB >> 3893129

Hypertension of polycystic kidney disease: mechanisms and hemodynamic alterations.

E Valvo, L Gammaro, N Tessitore, G Panzetta, A Lupo, C Loschiavo, L Oldrizzi, A Fabris, C Rugiu, V Ortalda.   

Abstract

32 polycystic kidney disease (PKD) patients, 16 with normal 16 with variably decreased renal function, were studied; 12 were normotensive, 20 were hypertensive. Mean arterial pressure (MAP) was 90 +/- 8 mm Hg in the normotensive group and 117 +/- 17 in hypertensive patients; plasma renin activity (PRA) was similar. The glomerular filtration rate (GFR) was lower, but not significantly, in the hypertensive group and plasma volume (PV) was higher in hypertensive patients (normotensive 40.25 +/- 3.47 ml/kg body weight; hypertensive 46.30 +/- 3.54). No correlation was found between MAP, and PRA or GFR but MAP correlated with PV. Cardiac output was higher in hypertensive patients (normotensive 3.48 +/- 0.70 l/min/m2; hypertensive 3.89 +/- 1.47), also total peripheral resistance was higher in the hypertensive group (normotensive 2,035 +/- 503 dyn/s/cm-5/m2; hypertensive 2,577 +/- 808). Cardiac output and PV showed a high degree of correlation, but no correlation was seen between total peripheral resistance and PV, or PRA. The hypertensive patients were divided into two groups: one with hypertension of less than 2 years duration and one with more than 2 years but with similar GFR, PRA, PV and hemodynamic pattern. Our data indicate that hypertension in PKD is volume-dependent; that the increase in PV was not related to the loss of GFR, and that the role of the renin-angiotensin system in maintaining the hypertensive state is not well defined. Hemodynamically hypertension is characterized by high cardiac output and total peripheral resistance independent of the duration of hypertension.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893129     DOI: 10.1159/000166929

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  4 in total

Review 1.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Autosomal recessive polycystic kidney disease.

Authors:  B S Kaplan; J Fay; V Shah; M J Dillon; T M Barratt
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

3.  ADPKD: Prototype of Cardiorenal Syndrome Type 4.

Authors:  Grazia Maria Virzì; Valentina Corradi; Anthi Panagiotou; Fiorella Gastaldon; Dinna N Cruz; Massimo de Cal; Maurizio Clementi; Claudio Ronco
Journal:  Int J Nephrol       Date:  2010-12-21

4.  Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice.

Authors:  Jonathan M Fonseca; Ana P Bastos; Andressa G Amaral; Mauri F Sousa; Leandro E Souza; Denise M Malheiros; Klaus Piontek; Maria C Irigoyen; Terry J Watnick; Luiz F Onuchic
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.